, Chaelin Hwang1
, Eunhye Kim2
, Hyejin Kim2
, Juhan Lee3
, Sun Jae Jung1,2,4
The Mental Health, Resilience, and Immune System in Transplantation (MeRIT) cohort was established to investigate psychological health, biological responses, and clinical outcomes in living-donor transplant recipients and donors during the perioperative and early post-transplant periods. Recruitment began at Severance Hospital in Seoul, Korea, in November 2024 and is ongoing through December 2026. By July 23, 2026, 651 participants had enrolled: 187 kidney recipients, 106 liver recipients, 202 kidney donors, and 156 liver donors. Recipients are assessed at admission, before discharge, 1 month after discharge, and 6 months after surgery; donors are assessed at admission, before discharge, and 6 months after surgery. Core mental health outcomes, loneliness, and family functioning are assessed repeatedly in both groups, while resilience and other psychosocial characteristics are assessed at baseline. Recipients also undergo assessments of cognitive function, heart rate variability, and immune and inflammatory biomarkers, with wearable monitoring limited to kidney recipients. Clinical information is linked from electronic medical records. The MeRIT cohort enables research into psychological adaptation and its relationships with biological and clinical outcomes. Access to de-identified data or collaborative analyses may be considered after the MeRIT study team reviews research proposals and applicable institutional procedures are followed.